Fusion Antibodies plc (FAB.L)

GBp 6.55

(0.77%)

Revenue Summary of Fusion Antibodies plc

Fusion Antibodies plc's latest annual revenue in 2023 was 1.13 Million GBP , down -60.84% from previous year.
Fusion Antibodies plc's latest quarterly revenue in 2023 FY was 1.13 Million GBP , down -60.84% from previous quarter.
Fusion Antibodies plc reported a annual revenue of 2.9 Million GBP in annual revenue 2022, down -39.55% from previous year.
Fusion Antibodies plc reported a annual revenue of 4.79 Million GBP in annual revenue 2021, up 15.22% from previous year.
Fusion Antibodies plc reported a quarterly revenue of 541 Thousand GBP for 2023 Q2, down 0.0% from previous quarter.
Fusion Antibodies plc reported a quarterly revenue of 595 Thousand GBP for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Fusion Antibodies plc (2023 - 2012)

Historical Annual Revenue of Fusion Antibodies plc (2023 - 2012)

Year	Revenue	Revenue Growth
2023	1.13 Million GBP	-60.84%
2022	2.9 Million GBP	-39.55%
2021	4.79 Million GBP	15.22%
2020	4.16 Million GBP	6.93%
2019	3.89 Million GBP	78.52%
2018	2.18 Million GBP	-18.91%
2017	2.69 Million GBP	40.59%
2016	1.91 Million GBP	29.21%
2015	1.48 Million GBP	62.9%
2014	909.29 Thousand GBP	25.76%
2013	723.04 Thousand GBP	78.53%
2012	404.99 Thousand GBP	0.0%

Year	Revenue	Revenue Growth
2023 FY	1.13 Million GBP	-60.84%
2023 Q2	541 Thousand GBP	0.0%
2023 Q4	595 Thousand GBP	0.0%
2022 Q4	1.03 Million GBP	0.0%
2022 FY	2.9 Million GBP	-39.55%
2022 Q2	1.86 Million GBP	0.0%
2021 FY	4.79 Million GBP	15.22%
2021 Q4	2.35 Million GBP	0.0%
2021 Q2	2.44 Million GBP	0.0%
2020 Q2	1.9 Million GBP	0.0%
2020 Q4	2.26 Million GBP	0.0%
2020 FY	4.16 Million GBP	6.93%
2019 Q4	2.14 Million GBP	0.0%
2019 Q2	1.75 Million GBP	0.0%
2019 FY	3.89 Million GBP	78.52%
2018 FY	2.18 Million GBP	-18.91%
2018 Q4	1.52 Million GBP	179.4%
2018 Q3	545.45 Thousand GBP	-17.1%
2018 Q2	658 Thousand GBP	-2.18%
2018 Q1	672.68 Thousand GBP	-47.31%
2017 Q2	1.41 Million GBP	195.53%
2017 Q4	1.27 Million GBP	0.0%
2017 FY	2.69 Million GBP	40.59%
2017 Q1	478.48 Thousand GBP	0.0%
2016 Q1	370.31 Thousand GBP	0.0%
2016 FY	1.91 Million GBP	29.21%
2016 Q4	478.48 Thousand GBP	0.0%
2016 Q3	478.48 Thousand GBP	0.0%
2015 Q4	370.31 Thousand GBP	0.0%
2015 Q3	370.31 Thousand GBP	62.9%
2015 FY	1.48 Million GBP	62.9%
2015 Q2	227.32 Thousand GBP	0.0%
2015 Q1	227.32 Thousand GBP	0.0%
2014 Q4	227.32 Thousand GBP	0.0%
2014 Q3	227.32 Thousand GBP	0.0%
2014 FY	909.29 Thousand GBP	25.76%
2013 FY	723.04 Thousand GBP	78.53%
2012 FY	404.99 Thousand GBP	0.0%

Peer Revenue Comparison of Fusion Antibodies plc

Name	Revenue	Revenue Difference